Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer

Clinical trial NCT01349959 · COMPLETED

Trial details

NCT number: NCT01349959
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Male Breast Carcinoma Recurrent Breast Carcinoma Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7 Triple-Negative Breast Carcinoma

Start date: 2011-08-15
Primary completion: 2014-03-27
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.